This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria's (MO) Q4 Earnings to Gain From Prudent Pricing & RRPs
by Zacks Equity Research
Altria (MO) gains from higher pricing as well as rising popularity of low risk tobacco products. However, declining cigarette sales volumes is a worry.
Philip Morris (PM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed at $69.62 in the latest trading session, marking a +0.17% move from the prior day.
Can Altria's Expansion in RRPs & Cannabis Enable a Revival?
by Zacks Equity Research
Altria (MO) strives to expand in RRPs and Cannabis to stay afloat, amid receding cigarette sales.
Philip Morris (PM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed at $67.87 in the latest trading session, marking a +0.67% move from the prior day.
Implied Volatility Surging for Philip Morris (PM) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Philip Morris (PM) stock based on the movements in the options market lately.
Will RRPs Curate a Comeback for Philip Morris (PM) in 2019?
by Zacks Equity Research
Philip Morris (PM) witnesses receding cigarette sales volumes. Nevertheless, the company's advancement in low-risk tobacco alternatives is encouraging.
Altria (MO) Confirms Deal With JUUL, Unveils Savings Plan
by Zacks Equity Research
Altria's (MO) deal with JUUL to boost strength in reduced risk products realm. Further, the company reiterates earnings view for 2018.
Altria Likely to Invest in Juul to Bolster E-Cigarettes Unit
by Zacks Equity Research
Altria (MO) is undertaking efforts to boost smokeless offerings. Per market reports, the company is considering an investment in Juul.
Can Altria (MO) Rebound From a Terrible 2018?
by Zacks Equity Research
Stringent FDA regulations have led to fading cigarette sales that are plaguing the performance of Altria. Nevertheless, growth in RRPs looks encouraging.
Tobacco Industry Outlook: RRPs Could Drive Recovery
by Zacks Equity Research
Stringent FDA regulations have led to fading cigarette sales, plaguing the performance of most tobacco stocks. Nevertheless, reduced risk products are viewed as a viable growth platform.
Philip Morris (PM) Stock Moves -1.89%: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed the most recent trading day at $85.43, moving -1.89% from the previous trading session.
The Zacks Analyst Blog Highlights: JPMorgan, Procter & Gamble, UnitedHealth, McDonald's and Philip Morris
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JPMorgan, Procter & Gamble, UnitedHealth, McDonald's and Philip Morris
Top Stock Reports for JPMorgan, Procter & Gamble and UnitedHealth
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan (JPM), Procter & Gamble (PG) and UnitedHealth (UNH)
Philip Morris (PM) Down 1.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Philip Morris (PM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed at $86.33 in the latest trading session, marking a +0.58% move from the prior day.
Company News For Nov 13, 2018
by Zacks Equity Research
Companies In The News Are: ABMD,ISCA,SAP,PM
Philip Morris (PM) Stock Moves -0.35%: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed the most recent trading day at $89.17, moving -0.35% from the previous trading session.
ECigarette Company Juul Labs is Now Worth $15 Billion
by Madeleine Johnson
Juul is a booming e-cigarette company thanks to its popularity with teens and young adults.
Philip Morris (PM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Philip Morris (PM) closed at $88.35, marking a +0.32% move from the previous day.
The Zacks Analyst Blog Highlights: Procter & Gamble, Philip Morris, Honeywell, Lockheed and Illumina
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, Philip Morris, Honeywell, Lockheed and Illumina
Top Analyst Reports for Procter & Gamble, Philip Morris & Honeywell
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Philip Morris (PM) and Honeywell (HON).
ETFs in Focus Post Philips Morris' Upbeat Earnings
by Zacks Equity Research
Philips Morris ETFs could experience some favorable price movement post strong Q3 results.
Will Pricing & Smokeless Unit Aid Altria's (MO) Q3 Earnings?
by Zacks Equity Research
Altria's (MO) Q3 performance to gain from strong pricing and strength in low risk alternatives. However, declining cigarette volumes is a concern.
Company News For Oct 19, 2018
by Zacks Equity Research
Companies in the news are: TXT, PM, SNA and AA
Trump vs. The Fed and PayPal, Intuitive Surgical Earnings Previews
by Ryan McQueeney
Ryan McQueeney discusses the Fed's decision to remain hawkish amid criticism from President Trump. He also recaps earnings results from Travelers, Blackstone, and Philip Morris. Later, he is joined by Dave Bartosiak to preview upcoming reports from PayPal and Intuitive Surgical.